A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

Clinical trial NCT07010471 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07010471
Sponsor: Praxis Precision Medicines
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Developmental and Epileptic Encephalopathy 1

Start date: 2025-07-09
Primary completion: 2026-12-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.